Technical Analysis for ANTX - AN2 Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
BB Squeeze Started | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Fell Below 50 DMA | Bearish | -0.93% | |
20 DMA Support | Bullish | -0.93% | |
BB Squeeze Ended | Range Expansion | -0.93% | |
Outside Day | Range Expansion | -0.93% |
Alert | Time |
---|---|
Bullish 180 Entry | 3 days ago |
Rose Above Previous Day's High | 3 days ago |
Down 3% | 3 days ago |
Fell Below 50 DMA | 3 days ago |
Down 2 % | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Infectious Diseases Microbiology Tuberculosis Bacteriology Nontuberculous Mycobacteria Serious Infectious Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 22.15 |
52 Week Low | 1.91 |
Average Volume | 125,596 |
200-Day Moving Average | 10.22 |
50-Day Moving Average | 2.21 |
20-Day Moving Average | 2.07 |
10-Day Moving Average | 2.10 |
Average True Range | 0.12 |
RSI (14) | 48.72 |
ADX | 26.23 |
+DI | 21.07 |
-DI | 15.83 |
Chandelier Exit (Long, 3 ATRs) | 1.92 |
Chandelier Exit (Short, 3 ATRs) | 2.26 |
Upper Bollinger Bands | 2.21 |
Lower Bollinger Band | 1.93 |
Percent B (%b) | 0.71 |
BandWidth | 13.47 |
MACD Line | -0.03 |
MACD Signal Line | -0.07 |
MACD Histogram | 0.034 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.21 | ||||
Resistance 3 (R3) | 2.21 | 2.18 | 2.19 | ||
Resistance 2 (R2) | 2.18 | 2.16 | 2.18 | 2.19 | |
Resistance 1 (R1) | 2.16 | 2.15 | 2.15 | 2.16 | 2.18 |
Pivot Point | 2.13 | 2.13 | 2.13 | 2.13 | 2.13 |
Support 1 (S1) | 2.11 | 2.11 | 2.10 | 2.11 | 2.08 |
Support 2 (S2) | 2.08 | 2.10 | 2.08 | 2.07 | |
Support 3 (S3) | 2.06 | 2.08 | 2.07 | ||
Support 4 (S4) | 2.06 |